| Filed On | Filing |
|---|---|
| 27 Oct 2026 | FORM 425 |
| 26 Oct 2026 |
8-K: Other Events
CINCINNATI, Ohio, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”), today announced that its Board of Directors has approved a one-for-ten (1-for-10) reverse stock split of the Company’s outstanding common... |
| 23 Oct 2026 | CURRENT REPORT |
| 23 Oct 2026 |
8-K: Other Events
On October 22, 2026, Onconetix, Inc. (the “Company”) made an additional advance of $500,000 to Realbotix, LLC (“Realbotix”) pursuant to that certain Grid Promissory Note, dated September 11, 2026 (the “Note”), previously disclosed in the... |
| 23 Oct 2026 | FORM 425 |
| 16 Oct 2026 | FORM ARS |
| 07 Oct 2026 | Proxy statement: annual meeting on November 10, 2026 |
| 17 Sep 2026 | PRELIMINARY PROXY STATEMENT |
| 14 Sep 2026 | CURRENT REPORT |
| 14 Sep 2026 | FORM 425 |
| 14 Sep 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR ANY U.S. STATE. SECURITIES LAWS, AND, UNLESS SO REGISTERED, MAY NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECT... |
| 08 Sep 2026 | PROSPECTUS |
| 03 Sep 2026 | EFFECT |
| 03 Sep 2026 | FORM 425 |
| 31 Aug 2026 | AMENDMENT NO. 1 TO FORM S-1 |
| 13 Aug 2026 | QUARTERLY REPORT |
| 12 Aug 2026 | REGISTRATION STATEMENT |
| 06 Aug 2026 | FORM 425 |
| 29 Jul 2026 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 27 Jul 2026 | SCHEDULE 13G |
Loading...
